Cyclacel Pharma (CYCC) Tops Q2 EPS by 8c
Tweet
Share
E-mailGet Alerts CYCC Hot Sheet
Price: $6.37 --0%
Financial Fact:
Research and development: 2.41M
Today's EPS Names:
ONEG, NDLS, EAF, More
Financial Fact:
Research and development: 2.41M
Today's EPS Names:
ONEG, NDLS, EAF, More
Join SI Premium – FREE
Cyclacel Pharma (NASDAQ: CYCC) reported Q2 EPS of ($0.46), $0.08 better than the analyst estimate of ($0.54).
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AppFolio (APPF) Tops Q2 EPS by 2c ; Offers Guidance
- Rhinebeck Bancorp (RBKB) Tops Q2 EPS by 24c
- Eagle Financial Services, Inc. (EFSI) Misses Q2 EPS by 38c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
